BTAI Stock Analysis: Buy, Sell, or Hold?
BTAI - BioXcel Therapeutics, Inc. Common Stock
$1.04
-0.06 (-5.45%)
▼
5d:
-25.71%
30d:
-15.45%
90d:
-8.77%
WAIT
LOW Confidence
Analysis Updated: Jul 7, 2026 12:00 AM ET
Earnings: Aug 11, 2026
Get Alerted When BTAI Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
2 traders called BTAI this week
100% bullish • 0 bearish
100% bullish • 0 bearish
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: BTAI is down 25.7% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: BTAI is down 25.7% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: BTAI is currently trading at $1.04, which is considered oversold relative to its 30-day fair value range of $1.10 to $1.31.
Technical Outlook: Technically, BTAI is in a strong uptrend. The price is currently testing key support at $1.04. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 5.5% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $14.00 (+1246.2%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, BTAI is in a strong uptrend. The price is currently testing key support at $1.04. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 5.5% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $14.00 (+1246.2%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$1.10 -
$1.31
Company Quality Score
52/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
77.4%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-5.5%)
- BULLISH: Trading 1246.2% below Wall St target ($14.00)
- WARNING: Recommendation downgraded due to -25.7% 5-day decline - wait for stabilization
Trading Range Analysis
30-Day Trading Range
$1.10 -
$1.31
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$1.04
Resistance Level
$1.46
Current Trend
Strong Uptrend
Technical data as of
Jul 7, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-0.68
Wall Street Target
$14.00
(+1246.2%)
Revenue Growth (YoY)
22.6%
Share & Embed Analysis
Last updated: July 08, 2026 12:57 AM ET
Data refreshes hourly during market hours. Next update: 1:57 AM
Data refreshes hourly during market hours. Next update: 1:57 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is BTAI showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Drug Manufacturers - Specialty & Generic Stocks
Top-rated stocks in Drug Manufacturers - Specialty & Generic by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NBIX
Neurocrine Biosciences I… |
STRONG BUY
25 analysts |
$196 | 64 BUY |
|
ZTS
Zoetis Inc |
BUY
20 analysts |
$118 | 59 HOLD |
|
UTHR
United Therapeutics Corp… |
STRONG BUY
15 analysts |
$665 | 57 HOLD |
|
BCRX
BioCryst Pharmaceuticals… |
STRONG BUY
12 analysts |
$22 | 59 HOLD |
|
LNTH
Lantheus Holdings Inc |
STRONG BUY
13 analysts |
$105 | 47 HOLD |
